Can a caregiver app stop pressure sores before they start?

NCT ID NCT06927479

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 10, 2026 · Last updated Sep 11, 2026 · Updated 1 time

Summary

Researchers at Akdeniz University are testing Care-Up, a mobile-friendly web tool that gives family caregivers structured guidance on skin care, pressure-injury prevention, urinary-risk signs, nutrition, hydration, and when to call a professional. The trial enrolls 66 patient-caregiver pairs from a home healthcare unit in Burdur, Turkey. Half receive Care-Up plus routine home care for eight weeks, and half receive routine home care alone. The main measure is change in pressure-injury risk on the Braden Scale, with nutrition and urinary indicators also tracked.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Care-Up, a mobile-compatible web-based decision support system for informal caregivers
What this could lead to
If it works, this could give family caregivers a practical digital tool to spot pressure-sore and urinary-infection risks earlier and act on them at home.
What could go wrong
The trial is small, with 66 patient-caregiver pairs, and it tests a support tool rather than a medicine. Results may not hold in other home-care settings, and caregivers may not keep using the app.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

66 people

The number who actually took part.

Started

Feb 2026

Finished

Apr 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

Children (under 18), adults (18 to 64) and older adults (65 and over)

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Patients registered with and receiving care from the Burdur State Hospital Home Healthcare Services Unit. Service registration required age 65 years or older or being bedridden. The study imposed no additional patient age restriction. 2. Patients with a Barthel Index total score of 0-20 (fully dependent) or 21-61 (severely dependent). 3. An informal caregiver providing care at home who could use a mobile device and the Care-Up web-based system. 4. Caregivers with an Adult Digital Literacy Scale score of at least 61 on the standardised 0-100 scale. 5. Caregivers who were literate in Turkish and voluntarily agreed to participate. Exclusion Criteria: 1. Patients with a Barthel Index score of 62 or above. 2. Patients with an acute medical condition, such as an infection requiring hospitalisation or a newly developed severe illness. 3. Caregivers with cognitive or technological limitations preventing use of Care-Up, including lack of access to the required technology. 4. Caregivers who were not literate in Turkish. 5. Patients with terminal illness and a short life expectancy. 6. Caregivers with severe cognitive impairment or an untreated psychiatric disorder affecting participation. 7. Patients without an informal caregiver at home. 8. Patients with an existing urinary infection identified from hospital records at baseline. 9. Patients with an existing pressure injury at baseline. Post-enrolment discontinuation criteria described in the study methods: * Patient-caregiver dyads moving outside the province. * Hospitalisation lasting more than one month after the study began. * Inability to complete the remaining study procedures after baseline assessments.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Support of the family as A caregiving system are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Burdur State Hospital Home Healthcare Services Unit

    Burdur, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.